COVID-19 Impact on Fisher & Paykel Healthcare Corporation Limited’s Revenue and Operations (Medical Devices)


Summary

Fisher & Paykel Healthcare Corporation Limited (Fisher & Paykel) designs, manufactures and commercializes products and systems for use in acute care, respiratory care, and obstructive sleep apnea. Headquartered in New Zealand with global manufacturing and sales reach. Fisher & Paykel’s product range include breathing circuits, chambers, continuous positive airway pressure devices, humidifiers, infant resuscitators, infant warmers, interfaces, masks, nasal cannula, software and data management, surgical devices, and accessories for neonatal care and adult patient care. The report, COVID-19 Impact on Fisher & Paykel Healthcare Corporation Limited’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.


Key Highlights

  • Fisher & Paykel’s multiple efforts to support hospitals and patients affected by COVID-19 has contributed to order intake for the first quarter 2020 being higher than expected by the market.
  • Fisher & Paykel has seen an increased global demand for ventilators for intensive care units since the outbreak of the COVID-19 pandemic.
  • Inspite of the heavy impact in Europe and rapid rise of COVID-19 cases in the US, the general outlook for sales has a significantly positive outlook.




Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Fisher & Paykel Healthcare Corporation Limited -

  • It provides insights on Fisher & Paykel Healthcare Corporation Limited’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
  • It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.




Reasons To Buy

  • An overview of how Fisher & Paykel Healthcare Corporation Limited will be affected by the COVID-19 pandemic.